IGXBio Overview

  • Founded
  • 2001
  • Status
  • Private
  • Employees
  • 1
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 3

IGXBio General Information


Developer of advanced DNA immunotherapies created to target HIV infection. The company's platform GenePro, is a proprietary DNA composition that synthetically mimics the virus in order to generate an immune response that is less toxic than current AIDS drug cocktails, enabling doctors to reduce infections particularly HIV.

Contact Information

Formerly Known As
ImmunoGenetix Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4220 Shawnee Mission Parkway
  • Suite B350
  • Fairway, KS 66205
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IGXBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Aug-2016 000.00 Completed Startup
4. Early Stage VC 0000 000.00 Completed Startup
3. Grant 01-Jan-2012 00000 Completed Startup
2. Accelerator/Incubator $350K Completed Startup
1. Angel (individual) 16-Feb-2006 $350K $350K Completed Startup
To view IGXBio’s complete valuation and funding history, request access »

IGXBio Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of advanced DNA immunotherapies created to target HIV infection. The company's platform GenePro, is a propriet
Fairway, KS
1 As of 2015
000000000000 000.00


nt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
0000 000000000
Houston, TX
00 As of 0000
000000000 - 000.00


quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000 000000000
Lebanon, NH
000 As of 0000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IGXBio Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAtrix Venture Capital-Backed Houston, TX 00 000.00 000000000 - 000.00
000000 Venture Capital-Backed Lebanon, NH 000 00000 0000000000 0 00000
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 000000000 00000
00000 0000000000 Formerly VC-backed Miramar, FL 00 00000 000000&0 00000
000000 Venture Capital-Backed Henrietta, NY 0 000.00 0000000000 000.00
You’re viewing 5 of 37 competitors. Get the full list »

IGXBio Executive Team (1)

Name Title Board Seat Contact Info
James Laufenberg Executive Chairman
To view IGXBio’s complete executive team members history, request access »

IGXBio Board Members (6)

Name Representing Role Since
David Tousley Self Board Member 000 0000
Edward Connolly Jr. Self Board Member 000 0000
Edward Stratemeier JD Self Board Member 000 0000
James Laufenberg IGXBio Executive Chairman 000 0000
William Garner MD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

IGXBio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IGXBio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
Kansas Bioscience Authority Government 000 0000 000000 0
Enterprise Center of Johnson County Not-For-Profit Venture Capital 000 0000 000000 0
To view IGXBio’s complete investors history, request access »